Skip to main content

Table 1 Baseline characteristics and risk factors of EECP and control groups

From: Evaluation of enhanced external counterpulsation therapy for nonarteritic anterior ischemic optic neuropathy

 

EECP

Control

P value

Age

53.81 ± 10.34

54.31 ± 9.41

0.419 a

Sex, M:F

23:14

23:16

0.776 b

Systemic risk factors

 Hypertension

17 (45.95%)

15 (38.46%)

0.509 b

 Diabetes mellitus

12 (32.43%)

19 (48.72%)

0.149 b

 Hypercholesterolemia

13 (35.14%)

13 (33.33%)

0.869 b

 Ischemic lesion on brain MRI

7 (18.92%)

10 (25.64%)

0.482 b

 Carotid artery plaque

8 (21.62%)

6 (15.38%)

0.483 b

 High blood viscosity

6 (16.22%)

4 (10.26%)

0.668 b

 Apnea

3 (8.11%)

4 (10.26%)

0.942 b

 Anemia

2 (5.41%)

4 (10.26%)

0.720 b

 Hepatitis B

2 (5.41%)

4 (10.26%)

0.720 b

 Hypoxia

3 (8.11%)

0 (0.00%)

0.220 b

 Alcoholism

2 (5.41%)

5 (12.82%)

0.471 b

 Smoking

0 (0.00%)

3 (7.69%)

0.258 b

No of eyes attacked

37 (100.00%)

39 (100.00%)

 
  1. EECP enhanced external counterpulsation
  2. aIndependent t-test
  3. bChi-square test